96 related articles for article (PubMed ID: 9630694)
21. Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein.
Ohta T; Takata K; Horiuchi S; Morino Y; Matsuda I
FEBS Lett; 1989 Nov; 257(2):435-8. PubMed ID: 2511042
[TBL] [Abstract][Full Text] [Related]
22. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
23. On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes.
Klimov AN; Kozhevnikova KA; Kuzmin AA; Kuznetsov AS; Belova EV
Biochemistry (Mosc); 2001 Mar; 66(3):300-4. PubMed ID: 11333154
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase.
da Silva EL; Abdalla DS; Terao J
IUBMB Life; 2000 Apr; 49(4):289-95. PubMed ID: 10995031
[TBL] [Abstract][Full Text] [Related]
25. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE
J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332
[TBL] [Abstract][Full Text] [Related]
26. Effect of phytosterols on copper lipid peroxidation of human low-density lipoproteins.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Nutrition; 2010 Mar; 26(3):296-304. PubMed ID: 19815390
[TBL] [Abstract][Full Text] [Related]
27. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.
Mackness MI; Abbott C; Arrol S; Durrington PN
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):829-34. PubMed ID: 8379937
[TBL] [Abstract][Full Text] [Related]
28. HDL enhances oxidation of LDL in vitro in both men and women.
Solakivi T; Jaakkola O; Salomäki A; Peltonen N; Metso S; Lehtimäki T; Jokela H; Nikkari ST
Lipids Health Dis; 2005 Oct; 4():25. PubMed ID: 16242018
[TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations.
Nourooz-Zadeh J; Tajaddini-Sarmadi J; Ling KL; Wolff SP
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):781-6. PubMed ID: 8611155
[TBL] [Abstract][Full Text] [Related]
30. Oxidation of low-density lipoprotein by copper and iron in phosphate buffer.
Kuzuya M; Yamada K; Hayashi T; Funaki C; Naito M; Asai K; Kuzuya F
Biochim Biophys Acta; 1991 Jul; 1084(2):198-201. PubMed ID: 1854806
[TBL] [Abstract][Full Text] [Related]
31. Interactions between Panax quinquefolium saponins and vitamin C are observed in vitro.
Li JP; Huang M; Teoh H; Man RY
Mol Cell Biochem; 2000 Jan; 204(1-2):77-82. PubMed ID: 10718627
[TBL] [Abstract][Full Text] [Related]
32. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
[TBL] [Abstract][Full Text] [Related]
33. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
Burkitt MJ
Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of dietary copper supplementation on serum lipids and antioxidant defenses in rats.
Galhardi CM; Diniz YS; Rodrigues HG; Faine LA; Burneiko RC; Ribas BO; Novelli EL
Ann Nutr Metab; 2005; 49(5):283-8. PubMed ID: 16088091
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
Bochkov VN; Tkachuk VA; Kuzmenko YS; Borisova YL; Bühler FR; Resink TJ
Mol Pharmacol; 1994 Feb; 45(2):262-70. PubMed ID: 8114675
[TBL] [Abstract][Full Text] [Related]
36. Selective uptake of cholesteryl esters from various classes of lipoproteins by HepG2 cells.
Brissette L; Charest MC; Falstrault L; Lafond J; Rhainds D; Tremblay C; Truong TQ
Biochem Cell Biol; 1999; 77(2):157-63. PubMed ID: 10438151
[TBL] [Abstract][Full Text] [Related]
37. Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation.
Bagnati M; Bordone R; Perugini C; Cau C; Albano E; Bellomo G
Biochem Biophys Res Commun; 1998 Dec; 253(2):235-40. PubMed ID: 9878521
[TBL] [Abstract][Full Text] [Related]
38. HDL2 can inhibit further oxidative modification of partially oxidized LDL.
Sakuma N; Saeki T; Ito T; Hibino T; Suzuki S; Kunimatsu M; Yamamoto K; Kitada S
J Atheroscler Thromb; 2010 Mar; 17(3):229-34. PubMed ID: 19942787
[TBL] [Abstract][Full Text] [Related]
39. Significant association of lipid peroxidation products with high density lipoproteins.
Hahn M; Subbiah MT
Biochem Mol Biol Int; 1994 Jul; 33(4):699-704. PubMed ID: 7981657
[TBL] [Abstract][Full Text] [Related]
40. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
Albers JJ; Slee A; Fleg JL; O'Brien KD; Marcovina SM
Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
